beta-hexachlorocyclohexane

Subscribe to Selected New Research on beta-hexachlorocyclohexane

29 relevant articles (0 outcomes, 7 trials/studies) found for this Bio-Agent

Description: RN given refers to (1alpha,2beta,3alpha,4beta,5alpha,6beta)-(+-)-isomer

Also Known As:

beta-HCH; beta-Lindane; beta-benzene hexachloride; beta-hexachlorobenzene; beta-hexachlorocyclohexane, (1alpha,2alpha,3alpha,4alpha,5alpha,6alpha)-isomer; beta-hexachlorocyclohexane, (1alpha,2alpha,3alpha,4alpha,5beta,6beta)-isomer; epsilon HCH; (1 alpha,2 beta,3 alpha,4 beta,5 alpha,6 beta)-1,2,3,4,5,6-hexachlorocyclohexane

Bio-Agent Context: Research Results

Organic Chemicals: 40

Hydrocarbons: 382

Halogenated Hydrocarbons: 28

Chlorinated Hydrocarbons: 135

Lindane: 456

beta-hexachlorocyclohexane: 29

Experts

1.	Matsumura, Fumio: 3 articles (01/2007 - 01/2002)
2.	Brock, John W: 2 articles (11/2007 - 02/2003)
3.	Zou, Enmin: 2 articles (09/2003 - 01/2002)
4.	Longnecker, Matthew P: 1 article (11/2007)
5.	Pierik, Frank H: 1 article (11/2007)
6.	Klebanoff, Mark A: 1 article (11/2007)
7.	Wong, Patrick S: 1 article (01/2007)
8.	Rothman, Nathaniel: 1 article (02/2003)
9.	Needham, Larry L: 1 article (02/2003)
10.	Bush, David: 1 article (02/2003)

Related Diseases

1.	Breast Neoplasms (Breast Cancer) 01/01/2007 - "CONCLUSION: Based upon these results, it was concluded that beta-HCH does act as a breast cancer promoter which exerts its tumorigenic activity via increased c-Neu expression." 01/01/2007 - "Promotion of breast cancer by beta-hexachlorocyclohexane in MCF10AT1 cells and MMTV-neu mice." 09/01/2003 - "Our results provide the in vitro mechanistic basis supporting the hypothesis that beta-HCH is one of the epigenetic risk factors assisting the progression of breast cancer cells to an advanced state of malignancy." 11/15/1990 - "After adjusting for age and parity by stepwise logistic regression, beta-HCH remained a significant risk factor of breast cancer" 11/15/1990 - "Occurrence of beta-hexachlorocyclohexane in breast cancer patients." Order ALL the reference details at left...
2.	Neoplasms (Cancer) 01/01/2007 - "In our in vivo studies, MMTV-Neu mice were injected with beta-HCH and observed for tumor formation over a 70 week period" 01/01/2007 - "METHODS: In this current study, we decided to investigate the long-term effects of beta-HCH in both the MCF10AT1 cell line which was derived from a normal epithelial cell line by stably transfecting a mutated c-Ha-ras and a MMTV-Neu mouse model for mammary cancer in vivo" 01/01/2007 - "To demonstrate beta-HCH's tumorigenic properties in an in vivo system, we used an MMTV-Neu mouse model.MMTV-Neu is a c-Neu overexpressing strain which has been shown to spontaneously develop mammary tumors at later stages of aging" 09/01/2003 - "An epidemiological study has indicated that exposure to beta-HCH could be one of the significant environmental risk factors for the development of human breast cancers" 07/01/1998 - "The concentrations of beta-HCH, PCB no. 156 and 170 were lower (not significant) in cancer tissue than in tissue from women with benign disease" Order ALL the reference details at left...
3.	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell) 02/01/2008 - "RESULTS: Risk of NHL, diffuse large B cell lymphoma (DLBCL) and chronic lymphatic leukaemia (CLL) did not increase with plasma levels of HCB, beta-HCH, p,p'-dichloro-diphenyl-dichloroethylene (DDE), or total and individual PCBs or their functional groups, in the overall study population" Order ALL the reference details at left...
4.	Body Weight (Weight, Body) 03/01/1997 - "The initial 3-day treatment with either beta-HCH or o,p'-DDT doubled the relative dry weight of the uterus: 102 +/- 8.6 mg/kg body weight (BW) and 104 +/- 4.4 mg/kg BW for beta-HCH and o,p'-DDT, respectively, compared to 49 +/- 1.9 mg/kg BW for vehicle-treated animals" 01/01/1992 - "Covariance analysis and log-linear models revealed correlation between increasing age and blood concentrations of HCB, beta-HCH, DDE and OCS, between relative body weight and HCB or DDE, between locality and all pollutants analyzed, and, finally, between fish consumption and OCS and Hg. Regarding the influence of locality on the body burden of pollutants it may be assumed that additional routes of uptake, e.g., via drinking water or air, might be important." 08/01/1988 - "Mice exposed to 0, 100, or 300 mg of beta-HCH/kg of diet were evaluated for changes in ovarian and uterine histology, body weight, lymphoid organ weight and histology, splenic cellularity, antigen-specific IgM and IgG plaque-forming cells (PFC), proliferative responses to mitogens, natural killer (NK) cell activity, and induction of cytolytic T lymphocytes" Order ALL the reference details at left...
5.	Premature Birth (Birth, Premature) 03/01/2003 - "There was also a suggestion of an increased risk of preterm birth among women in the highest tertile of beta-HCH (adjusted odds ratio 1.85, 95% CI = 0.94-3.66, p value for test of trend p = 0.08) compared with the lowest tertile" 03/01/2003 - "PURPOSE: To evaluate the associations of serum levels of p,pacute;-DDE and two other persistent organochlorine pesticides, beta-HCH and HCB, in relation to preterm birth" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Hexachlorobenzene (HCB)
2.	Dichlorodiphenyl Dichloroethylene (DDE)
3.	beta-hexachlorocyclohexane
4.	o,p'-DDT
5.	Polychlorinated Biphenyls (PCBs)
6.	DDT
7.	Protein-Tyrosine Kinases (Tyrosine Kinase)
8.	Estrogens (Estrogen)
9.	diphenyl (biphenyl)
10.	Mirex

Best Treatments:
Research Summary Report
on Breast Neoplasms

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 3583 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>